Related Experiment Video

Updated: Jun 6, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

404

Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity

Mario Cioce1,2, Mariamena Arbitrio3, Nicoletta Polerà3

  • 1Department of Medicine, Laboratory of Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, Rome 00128, Italy.

Cancer Drug Resistance (Alhambra, Calif.)
|December 3, 2024
PubMed

Insights

Cancer cells rewire lipid metabolism to resist therapy, becoming more aggressive and evading immune responses. Understanding these metabolic changes is key to developing new treatments for therapy-resistant cancers.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Research

Background:

  • Cancer therapy resistance remains a significant clinical challenge.
  • Altered lipid metabolism is a key adaptive strategy for cancer cells.
  • This metabolic reprogramming aids cancer aggressiveness and immune evasion.

Purpose of the Study:

  • To review the role of lipid metabolism alterations in cancer progression.
  • To highlight the clinical relevance of these metabolic findings for managing therapy resistance.

Main Methods:

  • Literature review focusing on lipid metabolism in cancer.
  • Analysis of mechanisms linking metabolic reprogramming to therapy resistance.
  • Examination of cancer cell and tumor microenvironment (TME) crosstalk.

Main Results:

  • Cancer cells extensively modify lipid metabolism to survive adverse conditions.
  • Metabolic reprogramming by specific cell populations within the TME contributes to overall ecosystem resistance.
  • These alterations are crucial for cancer cell aggressiveness and immune evasion.

Conclusions:

  • Understanding lipid metabolism alterations is vital for overcoming cancer therapy resistance.
  • Targeting metabolic pathways presents a promising strategy for developing novel combinatorial therapies.
  • Further research into these mechanisms can lead to improved management of resistant cancers.
Keywords:
Metabolic signalingimmune evasionmetastasistherapy resistancetumor microenvironment

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K